VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Biotechnology
UK biotechnology companies have already raised more than £1.5 billion ($1.97 billion) in 2018, surpassing the 2017 annual total of £1.2 billion. 28 September 2018
Biotechnology
After raising a bumper $96 million through its Nasdaq listing last week, Y-mAbs Therapeutics continued to gain value in its first day of trading, rising 50% to $24 per share. 24 September 2018
Biotechnology
San Franciscan microbial genomics specialist uBiome has raised $83 million in a series C financing round directed at funding an expansion into therapeutics. 21 September 2018
Biotechnology
A possible $1 billion initial public offering on the Hong Kong Stock Exchange could give the lie to rumors that the spate of bullish biotech listings in China is about to end. 20 September 2018
Pharmaceutical
Texas, USA-based Molecular Templates saw its share surge 54.22% to $6.25 by close of trading on Wednesday after is announced a potentially lucrative deal with Japan’s largest pharma company. 20 September 2018
Pharmaceutical
Swiss drugmaker Vifor Pharma has upped its equity stake in ChemoCentryx, a company with a current focus on late-stage candidates for patients with rare kidney diseases. 18 September 2018
Biotechnology
UK biopharma company Arecor has raised £6 million ($7.8 million) from new and existing investors to develop groundbreaking pharmaceutical drugs to transform the treatment of diabetes. 10 September 2018
Biotechnology
Oxford University biotech spinout Evox Therapeutics has raised £35.5 million ($45.4 million) in a series B financing round, with new money from Google’s venture capital unit GV, and Cowen Healthcare Investments. 3 September 2018
Biotechnology
Scalable model delivers '24% IPO rate' for clients, but don't call Mass Innovation Labs an incubator
Before joining Boston University to study biomedical engineering and chemistry, Mass Innovation Labs founder Amrit Chaudhuri was the youngest paid researcher at the MIT-affiliated Whitehead Institute for Biomedical Research, at age 15. 3 September 2018
Biotechnology
Boston, USA-based Vertex Pharmaceuticals and the UK’s Genomics have announced a three-year collaboration to use human genetics and machine learning to improve discovery of targets for precision medicines. 30 August 2018
Biotechnology
A leading Chinese investment group has taken a stake in Oxford BioDynamics (AIM: OBD), a UK biotech focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry. 22 August 2018
Biotechnology
Amphion Innovations, a developer of medical, life science, and technology businesses, has announced that 3 million shares in partner company, Motif Bio have been sold directly to an institutional investor at 33.5 pence per share. 21 August 2018
Biotechnology
Money flooded into initial public offerings and venture financing for young biotech companies in the first half of 2018, according to a report by Vantage, the editorial arm of the intelligence firm Evaluate. 20 August 2018
Pharmaceutical
Anglo-American antibiotics developer Summit Therapeutics opened up more than 10% on Thursday following news that it is to receive further US government funding for its C difficile infection (CDI) drug candidate. 16 August 2018
Biotechnology
Accelerator Life Science Partners and the University of Texas MD Anderson Cancer Center have announced the launch of Magnolia Neurosciences, a drug discovery and development company focused on creating a novel class of neurological therapies. 13 August 2018
Biotechnology
A Chinese oncology company that is developing biosimilars and innovative drugs, has announced the completion of a Series B financing round, raising $102 million in capital. 9 August 2018
Biotechnology
Digital medicine company Akili Interactive Labs, an independent affiliate of the biotech company PureTech Health, has announced an additional $13 million worth of investment in its ongoing Series C funding campaign, which now totals $68 million. 9 August 2018
Biotechnology
A new biotech company launched on Wednesday with a $60 million Series A financing funded by Third Rock Ventures and Takeda. 8 August 2018
Biotechnology
Samumed, a US biopharmaceutical startup, has concluded its Series A fundraising campaign having raised $438 million based on a valuation of $12 billion. 6 August 2018
article
With the aim of expanding their horizon in oncology with a new set of T cell receptor targets, the USA’s Regeneron Pharmaceutical has struck a deal with fellow biotech bluebird bio. 6 August 2018
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze